India markets: Inflation up, RBI intensifies currency defence efforts, liquidity steps
RBI defends INR.
Group Research - Econs, Radhika Rao13 Oct 2026
Article image
Photo credit: Adobe Stock Photo
Read More

The RBI added another layer to its rupee defence strategy over the weekend, unveiling fresh FX and liquidity measures(see note). Steps revolved around curbing speculative demand, tightening regulations around FX derivative contracts and diverting oil dollar demand away from the spot market to stabilise the currency. Rupee rallied close to 1% at open, with attempts to return towards 96/USD thereafter attracting intervention bids. The breadth of the restrictions points to the record low of 97.00 as a de facto policy red line for USD/INR in the near-term. Back in 2013, the INR had depreciated sharply in the run-up to measures in July but appreciated thereafter due to a combination of macroprudential measures, rate response as well as resumption in inflows and the US Fed’s decision to pause on rates. To that extent, a durable turnaround in the currency will also require negative global triggers to subside. The latest announcements may not fully quell speculation over further policy action. Should depreciation pressures intensify again, markets are likely to price a higher probability of a front-loaded and more aggressive rate-hike cycle.

Accompanying liquidity measures – raising the daily minimum CRR requirement and OMOs - are consistent with the RBI’s 7 October signal that excess system liquidity would be progressively drained to keep overnight money-market rates anchored closer to the repo rate, reinforcing the tightening cycle. The surplus slipped below INR 4trn by late last week and ahead of temporary drain on the cash balances by way of currency leakage, tax outflows, and FX intervention sales. More tranches of open market operations are likely in the making, with markets anticipating a total of INR 1.0-1.5trn this quarter. Against this backdrop, the 10y bond yield neared a three-year high on Monday, as RBI’s liquidity measures fuelled the sell-off. On the markets end, foreign reserves have come off high but are still substantial, with the import cover at a comfortable ~10 months of import cover. In the near-term, barring a rollback of these macroprudential restrictions, USDINR is likely to be rangebound within 95.20-96.20, while bond yields will be firm due to ongoing liquidity measures, firm oil prices and elevated global yields.

September inflation rose to 5.5% yoy, lower than our forecast at 5.7%, but at the fastest pace since late-2024. Food inflation will continue to be a key variable for the headline in midst of below normal monsoon and El Nino impact, with pressures broadening beyond perishables to pulses, sugar, edible oil, cereals etc. Core inflation strengthened to 4.5% yoy from 4.3% in Aug (and 3.1% in Jan26), while the share of the inflation basket running above 4% rose to ~36% by Sep26. 3QFY (Oct-Dec) inflation is expected to edge past 6% on a low base as well as broader pressures from food, fuel and services. A gradual rise in the core gauge aligns with the central bank's view that price risks are no longer benign. In the face of higher headline prints, we expect the RBI to keep the door open for another rate hike in December 2026.

Radhika Rao

Senior Economist – Eurozone, India, Indonesia
radhikarao@dbs.com

 



Subscribe
here to receive our economics & macro strategy materials.
To unsubscribe, please click here.

Topic

Disclaimers and Important Notices

GENERAL DISCLOSURE/ DISCLAIMER (For Macroeconomics, Currencies, Interest Rates, Digital Assets or Commodities)[1]

The information herein is published by DBS Bank Ltd and/or DBS Bank (Hong Kong) Limited (each and/or collectively, the “Company”). It is based on information obtained from sources believed to be reliable, but the Company does not make any representation or warranty, express or implied, as to its accuracy, completeness, timeliness or correctness for any particular purpose. Opinions expressed are subject to change without notice. This research is prepared for general circulation.  Any recommendation contained herein does not have regard to the specific investment objectives, financial situation and the particular needs of any specific addressee. The information herein is published for the information of addressees only and is not to be taken in substitution for the exercise of judgement by addressees, who should obtain separate legal or financial advice. The Company, or any of its related companies or any individuals connected with the group accepts no liability for any direct, special, indirect, consequential, incidental damages or any other loss or damages of any kind arising from any use of the information herein (including any error, omission or misstatement herein, negligent or otherwise) or further communication thereof, even if the Company or any other person has been advised of the possibility thereof. The information herein is not to be construed as an offer or a solicitation of an offer to buy or sell any securities, futures, options or other financial instruments or to provide any investment advice or services. The Company and its associates, their directors, officers and/or employees may have positions or other interests in, and may effect transactions in securities mentioned herein and may also perform or seek to perform broking, investment banking and other banking or financial services for these companies.  The information herein is not directed to, or intended for distribution to or use by, any person or entity that is a citizen or resident of or located in any locality, state, country, or other jurisdiction (including but not limited to citizens or residents of the United States of America) where such distribution, publication, availability or use would be contrary to law or regulation.  The information is not an offer to sell or the solicitation of an offer to buy any security in any jurisdiction (including but not limited to the United States of America) where such an offer or solicitation would be contrary to law or regulation.

[#for Distribution in Singapore] This report is distributed in Singapore by DBS Bank Ltd (Company Regn. No. 196800306E) which is Exempt Financial Advisers as defined in the Financial Advisers Act and regulated by the Monetary Authority of Singapore. DBS Bank Ltd may distribute reports produced by its respective foreign entities, affiliates or other foreign research houses pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the report is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, DBS Bank Ltd accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact DBS Bank Ltd at 65-6878-8888 for matters arising from, or in connection with the report.

DBS Bank Ltd., 12 Marina Boulevard, Marina Bay Financial Centre Tower 3, Singapore 018982. Tel: 65-6878-8888. Company Registration No. 196800306E. 

DBS Bank Ltd., Hong Kong Branch, a company incorporated in Singapore with limited liability.  18th Floor, The Center, 99 Queen’s Road Central, Central, Hong Kong SAR.

DBS Bank (Hong Kong) Limited, a company incorporated in Hong Kong with limited liability.  11th Floor, The Center, 99 Queen’s Road Central, Central, Hong Kong SAR.


[1] This disclaimer may not apply if the applicable assets fall within the definition of  'financial instruments' that are set out in Article 2(1) EU MAR (e.g. financial instruments that are traded on a regulated market, MTF or OTF, etc.). Section C of Annex I of MiFID2 specifies these 'financial instruments'.